glutamine has been researched along with Breast Neoplasms in 124 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (4.84) | 18.7374 |
| 1990's | 9 (7.26) | 18.2507 |
| 2000's | 19 (15.32) | 29.6817 |
| 2010's | 61 (49.19) | 24.3611 |
| 2020's | 29 (23.39) | 2.80 |
| Authors | Studies |
|---|---|
| Jhu, JW; Lin, SC; Lin, ZH; Peng, IC; Yan, JB | 1 |
| Andrade, N; Ferreira, AC; Martel, F; Rodrigues, I; Silva, C; Soares, ML | 1 |
| Cao, J; Li, L; Wang, J; Yang, K | 1 |
| Gudjonsson, T; Halldorsson, S; Karvelsson, ST; Kotronoulas, A; Rolfsson, O; Wang, Q | 1 |
| Barbas, C; Baszanowska, W; Huynh, TYL; Nizioł, M; Oscilowska, I; Palka, J; Sáiz, J | 1 |
| Fu, X; Huang, X; Lai, S; Li, H; Li, Q; Li, Z; Liu, Y; Qu, F; Wang, C; Yao, W; Yu, J; Zhang, D; Zhong, X | 1 |
| Koo, JS; Ryu, HJ | 1 |
| Bennett, I; Galloway, G; Irvine, J; Lloyd, T; Malycha, P; Mountford, C; Naude, N; Santamaría, G; Watson, J | 1 |
| Chen, Q; Chen, Y; Hu, Z; Jin, H; Ju, S; Li, H; Lin, W; Sun, F; Sun, Y; Wang, C; Wang, L; Wang, X; Wang, Y; Zhou, Q | 1 |
| Chen, Z; Jian, H; Wang, J; Wen, T; Zhang, Y | 1 |
| Athineos, D; Blyth, K; Boldrini, C; Däbritz, JHM; Dhayade, S; Gjerga, E; Hedley, A; Hernandez-Fernaud, JR; Jamieson, C; Johnson, RM; Kamphorst, JJ; Kay, EJ; Kirschner, K; Koulouras, G; Lilla, S; Loayza-Puch, F; Mazzone, M; McGregor, G; Miller, C; Neilson, LJ; Park, M; Paterson, K; Riera-Domingo, C; Saez-Rodriguez, J; Stepanova, E; Sumpton, D; Tardito, S; Zagnoni, M; Zanivan, S | 1 |
| Bhattacharyya, M; Jariyal, H; Kumar, AS; Shah, RP; Srivastava, A; Thakkar, H | 1 |
| Chen, S; Li, J; Liu, J; Sun, H; Sun, M; Wang, G; Wang, Q; Wu, M; Zhou, F; Zhou, Z | 1 |
| Abedi-Gaballu, F; Baradaran, B; Cho, WC; Dehghan, G; Emami, A; Eslami, F; Kamal Kazemi, E; Mansoori, B; Salehzadeh, SA | 1 |
| Basu, S; Bawa-Khalfe, T; Ho, C; Khan, AF; Lin, CY; Premaratne, A | 1 |
| Chen, H; Dai, Y; Kang, Y; Pei, S; Xia, Y; Xie, H; Yang, L; Zhang, P; Zhao, S; Zheng, M | 1 |
| Fan, J; Li, S; Li, Y; Long, X; Nephew, KP; Tu, J; Wang, F; Xu, C; Zeng, H | 1 |
| Gâz, ȘA; Lungu, IA; Moldovan, OL; Rusu, A; Sandulea, A | 1 |
| Rugo, HS; Vidula, N; Yau, C | 1 |
| Daigo, Y; Maruyama, R; Mezawa, Y; Miyagi, Y; Orimo, A; Seimiya, H; Takano, A; Wang, T; Yamashita, T; Yang, L; Yokose, T | 1 |
| Blank, B; Cerione, RA; Cluntun, AA; Druso, JE; Erickson, JW; Greene, KS; Katt, WP; Le, HH; Lin, MJ; Lukey, MJ; Ramachandran, S; Wang, ZE | 1 |
| Byrne, FL; Geisslinger, G; Grösch, S; Gruber, L; Hancock, SE; Hoehn, KL; Olzomer, EM; Schömel, N; Shah, D; Turner, N; Wegner, MS | 1 |
| Audet-Walsh, E; Bourmeau, G; Dufour, CR; Giguère, V; Kuasne, H; Li, X; McGuirk, S; Park, M; Scholtes, C; St-Pierre, J; Vernier, M | 1 |
| Arevalillo, JM; Díaz-Almirón, M; Espinosa, E; Fresno Vara, JÁ; Gámez-Pozo, A; López-Camacho, E; López-Vacas, R; Maín, P; Navarro, H; Prado-Vázquez, G; Trilla-Fuertes, L; Zamora, P; Zapater-Moros, A | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Alba-Castellón, L; Baulida, J; Bruch-Oms, M; Comerma, L; Duñach, M; García de Herreros, A; Mestre-Farrera, A; Peña, R; Pozo, ÓJ; Quintela-Fandino, M; Rodríguez-Morató, J | 1 |
| Abuarqoub, R; Alhusban, A; Bahader, M; Hamadneh, L | 1 |
| Othman, AH; Pratap, J; Tandon, M; Winogradzki, M | 1 |
| Abbott, KL; Arevalo, OD; Coloff, JL; Dong, W; Ho, K; Hosios, AM; Iliopoulos, O; Keibler, MA; Kelleher, JK; Korthauer, KD; Lee, J; Liu, N; Moon, SJ; Phanse, AS; Stephanopoulos, G; Sullivan, LB; Vander Heiden, MG | 1 |
| Grinde, MT; Halldorsson, S; Johannsson, F; Karvelsson, ST; Moestue, SA; Mælandsmo, GM; Rolfsson, O; Seip, K; Sigurdsson, A; Wang, Q | 1 |
| Bhopal, T; Dwivedi, A; Kamireddy, KR; Khumukcham, SS; Manavathi, B; Mukta, S; Padala, C; Penugurti, V | 1 |
| Craze, ML; El Ansari, R; Ellis, IO; Green, AR; McIntyre, A; Rakha, EA | 1 |
| Allasia, A; Deutz, NEP; Engelen, MPKJ; Klimberg, VS | 1 |
| Aleskandarany, MA; Cheung, H; Coimbra, NDM; Craze, ML; Diez-Rodriguez, M; El-Ansari, R; Ellis, IO; Green, AR; Jewa, N; Nolan, CC; Rakha, EA; Soria, D; Wai Cheng, K | 1 |
| Brantley-Sieders, DM; Chen, J; Edwards, DN; Kim, LC; Ngwa, VM; Reynolds, AB; Shiuan, E; Wang, S | 1 |
| Choi, HJ; Lee, H; Lee, HB; Lee, HJ; Park, HK; Ryu, JE; Son, WC; Yu, ES | 1 |
| Blyth, K; Dhayade, S; Dornier, E; Mackay, G; Macpherson, IR; Marco, S; Mitchell, L; Nixon, C; Norman, JC; Novo, D; Pallares, M; Rabas, N; Rainero, E; Sumpton, D | 1 |
| Benson, CC; Clish, CB; Gonzalez Herrera, KN; Gorham, JM; Haigis, MC; Ishikawa, Y; Lin, JR; Mulei, S; Ringel, A; Satterstrom, FK; Seidman, JG; Sorger, PK; Souza, A; Spinelli, JB; Yoon, H; Zaganjor, E | 1 |
| Cha, YJ; Kim, ES; Koo, JS | 1 |
| Kingston, NM; Monti, S; Stampouloglou, E; Varelas, X; Yang, CS; Zhang, L | 1 |
| Brooks, M; Luo, M; Wicha, MS | 1 |
| Freidman, N; Guan, YF; Holst, J; Krycer, JR; Pang, A; Quek, LE; Ryan, R; Turner, N; van Geldermalsen, M; Wang, Q | 1 |
| Boldes, T; Elazar, A; Journo, S; Klein, A; Merenbakh-Lamin, K; Pasmanik-Chor, M; Rubinek, T; Spitzer, A; Wolf, I; Zinger, L | 1 |
| Appelbe, OK; Bindokas, VP; Collins, TN; Efimova, EV; Flor, AC; Kron, SJ; Lee, SS; Liu, Y; Ramamurthy, A; Ricco, N; Warrington, S; Wolfgeher, DJ | 1 |
| Gwangwa, MV; Joubert, AM; Visagie, MH | 1 |
| Grinde, MT; Haugen, MH; Henriksen, IM; Hilmarsdottir, B; Kim, J; Moestue, SA; Mælandsmo, GM; Rye, MB; Tunset, HM | 1 |
| Brodsky, AN; Harcum, SW; Odenwelder, DC | 1 |
| Baldi, R; Chang, CY; Liu, J; Liu, W; Liu, X; Locasale, JW; McDonnell, DP; Park, S; Safi, R | 1 |
| Jung, WH; Kim, DH; Kim, S; Koo, JS | 1 |
| Jung, WH; Kim, S; Koo, JS | 1 |
| Barupal, DK; Brockmöller, SF; Budczies, J; Denkert, C; Dietel, M; Fiehn, O; Griffin, JL; Kleine-Tebbe, A; Müller, BM; Orešič, M; Richter-Ehrenstein, C | 1 |
| Foerster, B; Harris, RE; Ichesco, E; Khabir, T; Sen, A; Wood, L; Wright, B; Zick, SM; Zwickey, H | 1 |
| Ambs, S; Chan, K; Dorsey, TH; Edelman, DC; Hsu, TY; Ioffe, OB; Issaq, HJ; Karoly, ED; Killian, JK; Kittles, RA; Kurley, SJ; Lee, DH; Mathé, EA; Meltzer, PS; Mishra, P; Prieto, D; Putluri, N; Putluri, V; Samanta, S; Schiff, R; Sonavane, R; Sreekumar, A; Starks, AM; Stephens, RM; Stevenson, HS; Terunuma, A; Veenstra, TD; Wallace, TA; Westbrook, TF; Wulff, J; Yang, Y; Yfantis, HG; Yi, M; Zhou, M | 1 |
| Gad, AKB; Johansson, S; Spielmann, T; Widengren, J; Xu, L | 1 |
| Chiarugi, P; Morandi, A | 1 |
| Bahl, M; Barnes, T; Bell, K; Califaretti, N; Campbell, C; DiSebastiano, KM; Dubin, JA; Hanning, R; Mourtzakis, M; Russell, C; Vance, V | 1 |
| Budczies, J; Denkert, C; Dietel, M; Fiehn, O; Györffy, B; Pfitzner, BM; Radke, C; Winzer, KJ | 1 |
| Chihanga, T; Kennedy, MA; Shi, Z; Wang, B; Weber, GF | 1 |
| Clarke, R; Cook, KL; Demas, DM; Eltayeb, AE; Facey, CO; Hilakivi-Clarke, LA; Schwartz-Roberts, JL; Shajahan-Haq, AN; Warri, AM | 1 |
| Fu, A; Song, Y; Yu, Z; Zhang, E | 1 |
| Chen, S; Chen, Z; Wang, Y; Warden, C | 1 |
| Cliffel, DE; Fingleton, B; Kimmel, DW; Venmar, KT | 1 |
| Bharti, S; Bhujwalla, ZM; Dang, CV; Han, L; Huijts, CM; Korangath, P; Mori, N; Sadik, H; Santa-Maria, CA; Stearns, V; Sukumar, S; Teo, WW; Tsai, H; Wildes, F; Zhang, Z | 1 |
| Cenk, U; Eda, K; Murat, T; Uzer, K | 1 |
| Brischwein, M; Demmel, F; Huber, F; Pfister, C; Wolf, B; Wolf, P | 1 |
| Bankson, J; Blonska, M; Carlock, C; Chen, J; Choi, HH; Chou, PC; Cody, D; Delacerda, J; Elliott, A; Fuentes-Mattei, E; Grabiner, B; Gully, C; Habra, M; Hazle, J; Hsieh, YC; Huang, Y; Kingsley, C; Lee, J; Lee, MH; Li, L; Lin, X; Parreno, K; Phan, L; Pusztai, L; Ramirez, M; Rizk, N; Samudio, I; Shao, Y; Shiang, C; Shin, JH; Skerl, S; Su, CH; Tseng, C; Velazquez-Torres, G; Vu, T; Wang, E; Wang, H; Wang, Y; Webb, D; Wen, YY; Weng, S; Wu, Y; Xia, X; Yang, W; Yeung, SC; Zhang, A; Zhou, Z | 1 |
| Aguilar-Mahecha, A; Amir, E; Andrzejewski, S; Annis, MG; Basik, M; Blagih, J; Clemons, M; Dong, Z; Dupuy, F; Gao, D; Jones, RG; Leung, S; Omeroglu, A; Siegel, PM; St-Pierre, J; Tabariès, S; Vincent, EE | 1 |
| Brantley-Sieders, DM; Chen, J; Edwards, DN; Hwang, Y; Kim, LC; Lu, P; Santapuram, PR; Stirdivant, SM; Ye, F; Youngblood, VM | 1 |
| Geck, RC; Toker, A | 1 |
| Gokulapriya, G; Lakshmi, BS; Sathya, S; Sudhagar, S | 1 |
| Aldashev, AA; Asambaeva, DA; Isakova, ZhT; Makieva, KB; Sultangazieva, BB | 1 |
| Anderson, GR; Baldi, R; Chang, CY; Dewhirst, MW; Jasper, JS; Liu, T; Liu, X; Locasale, JW; McDonnell, DP; Park, S; Rathmell, JC; Safi, R; Wood, KC | 1 |
| Hyun, S; Kim, S; Lee, Y; Yu, J | 1 |
| Budczies, J | 1 |
| Gao, Y; Liang, Z; Niu, L; Teng, M; Zhang, Q | 1 |
| Aguirre-Ghiso, JA; Burkel, B; Castracane, J; Condeelis, JS; Denu, JM; Fan, J; Keely, PJ; Morris, BA; Ponik, SM | 1 |
| Cacace, A; Sboarina, M; Sonveaux, P; Vazeille, T | 1 |
| Choi, YH; Dilshara, MG; Jeong, JW; Kim, GY; Lee, S; Neelaka Molagoda, IM; Park, SR; Prasad Tharanga Jayasooriya, RG | 1 |
| Ghosh, S; Maity, P; Mallick, P; Roy, S | 1 |
| Bi, C; Cui, C; Dou, QP; Fan, Y; Xiao, Y; Zhang, X | 1 |
| Anyanwu, SN; Bunker, CH; Ezeome, ER; Ferrell, RE; Garte, SJ; Kuller, LH; Okobia, MN; Taioli, E; Uche, EE; Zmuda, JM | 1 |
| Kaufmann, Y; Klimberg, VS; Luo, S; Todorova, VK | 1 |
| Friday, E; Oliver, R; Turturro, F; Welbourne, T | 1 |
| Chi, JT; Kung, HN; Marks, JR | 1 |
| Howell, A; Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Pestell, RG; Sotgia, F | 1 |
| Farias, JW; Furtado, FS; Guimarães, SB; Silva Filho, AR; Vasconcelos, PR | 1 |
| Belka, G; Chodosh, LA; Kung, HF; Lieberman, BP; Ploessl, K; Qu, W; Thompson, CB; Wang, L; Wise, DR; Zha, Z | 1 |
| Beland, FA; Pogribny, IP; Simpson, NE; Tryndyak, VP | 1 |
| Diamandis, EP; Dimitromanolakis, A; Drabovich, AP; Pavlou, MP | 1 |
| Bajaj, A; Braunlin, M; Cady, AM; Irving, LR; Lucci, A; Madan, S; Raythatha, MR; Singh, B; Tai, K | 1 |
| Beland, FA; Pogribna, M; Pogribny, IP; Simpson, NE; Tryndyak, VP | 1 |
| Blenis, J; Buel, GR; Cantley, LC; Choo, AY; Erikson, RL; Hoffman, GR; Jang, YJ; Kim, BY; Kim, SG; Lee, KW; Poulogiannis, G | 1 |
| Bhattacharyya, S; Kaufmann, Y; Klimberg, VS; Maners, A; Rubio, I; Smith, M; Suva, LJ; Todorova, V | 1 |
| LORINCZ, AB; RYAN, WL | 1 |
| Makino, H | 1 |
| Abcouwer, SF; Bobrovnikova-Marjon, EV; Marjon, PL | 1 |
| Abcouwer, SF; Barbash, O; Bobrovnikova-Marjon, EV; Marjon, PL; Vander Jagt, DL | 1 |
| Basilico, C; Cavassa, S; Comoglio, PM; Mazzone, M; Michieli, P; Naldini, L; Pennacchietti, S; Risio, M | 1 |
| Balmaceda, CM; Gooch, CL; Hesdorffer, CS; Stubblefield, MD; Troxel, AB; Vahdat, LT | 1 |
| Edwards, RA; Glover, JN; Lee, MS; Thede, GL | 1 |
| Aribi, A; Cheng, JM; Ding, M; Rao, K; Shah, P | 1 |
| Blanch, HW; Clark, DS; Forbes, NS; Meadows, AL | 1 |
| Jones, JB; Peterson, DE; Petit, RG | 1 |
| Alonso, FJ; Campos-Sandoval, JA; de la Rosa, V; Donadio, AC; Lobo, C; Márquez, J; Martín-Rufián, M; Matés, JM; Segura, JA; Tosina, M | 1 |
| Arnold, S; Brown, MA; Buchanan, D; Chenevix-Trench, G; Couch, FJ; Farrugia, DJ; Goldgar, DE; Healey, S; Henderson, BR; Lakhani, SR; Lovelock, PK; Mok, MT; Spurdle, AB; Tavtigian, SV | 1 |
| Akbari, MR; Bismar, TA; Darnel, A; Fafard, E; Foulkes, WD; Ghadirian, P; Giroux, S; Hamel, N; Martin, G; Narod, SA; Poll, A; Robidoux, A; Rousseau, F; Royer, R; Sabbaghian, N; Tischkowitz, M | 1 |
| Briand, P; Lykkesfeldt, AE | 1 |
| Feuer, L; Gergely, P; Kalmár, L; Láng, I; Nèkám, K; Török, K | 1 |
| Eigenbrodt, E; Failing, K; Hugo, F; Mazurek, S | 1 |
| Berns, CM; Corry, PM; Galoforo, SS; Guan, KL; Gupta, AK; Lee, YJ; Martinez, AA; Wu, X | 1 |
| Abcouwer, SF; Collins, CL; Souba, WW; Wasa, M | 2 |
| Berns, CM; Chen, JC; Corry, PM; Davis, BH; Galoforo, SS; Lee, YJ; Sim, JE; Spitz, DR | 1 |
| Cao, Y; Hutchins, LF; Klimberg, VS; Rubio, IT; Westbrook, KC | 1 |
| Abcouwer, SF; Meguid, RA; Schwarz, C | 1 |
| Alba, F; Cueva, C; Martínez, JM; Prieto, I; Ramírez, M; Ramírez, MJ | 1 |
| Aledo, JC; Alonso, FJ; Campos, JA; Del Castillo-Olivares, A; Gómez-Fabre, PM; Márquez, J; Núñez De Castro, I | 1 |
| Cockerham, MB; Lerchie, SB; Weinberger, BB | 1 |
| Brown, M; Colditz, GA; Haiman, CA; Hankinson, SE; Hunter, DJ; Speizer, FE; Spiegelman, D; Willett, WC | 1 |
| Deryugina, EI; Marchenko, GN; Monosov, EZ; Quigley, JP; Ratnikov, BI; Rozanov, DV; Strongin, AY | 1 |
| Arimura, GK; Wu, MC; Yunis, AA | 1 |
| Eigenbrodt, E; Hugo, F; Mazurek, S; Zander, U | 1 |
| Ollenschläger, G; Roth, E; Simmel, A | 1 |
| Förster, H; Fortmeyer, HP; Kallinowski, F; Runkel, S; Vaupel, P | 1 |
10 review(s) available for glutamine and Breast Neoplasms
| Article | Year |
|---|---|
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.
Topics: Breast Neoplasms; Female; Glucose; Glutamine; Humans; Lipids; MicroRNAs; RNA, Circular; RNA, Long Noncoding; RNA, Untranslated | 2022 |
Glutamine metabolism in breast cancer and possible therapeutic targets.
Topics: Amino Acids; Breast Neoplasms; Carbon; Cell Line, Tumor; Female; Glucose; Glutamine; Humans | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
Topics: Breast Neoplasms; Female; Glutamine; Humans; Metabolomics | 2018 |
Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Topics: Amino Acid Transport Systems; Breast Neoplasms; Female; Glutamine; Humans; Models, Biological | 2018 |
Metabolic implication of tumor:stroma crosstalk in breast cancer.
Topics: Breast Neoplasms; Female; Glucose; Glutamine; Humans; Metabolic Networks and Pathways; Models, Biological; Stromal Cells; Tumor Microenvironment | 2014 |
Nonessential amino acid metabolism in breast cancer.
Topics: Animals; Arginine; Breast Neoplasms; Cysteine; Diet Therapy; Female; Food Deprivation; Glutamic Acid; Glutamine; Glycine; Humans; Metabolic Networks and Pathways; Proline; Serine | 2016 |
[Metabolome analysis of solid tumors].
Topics: 4-Aminobutyrate Transaminase; beta-Alanine; Biomarkers, Tumor; Breast; Breast Neoplasms; Colonic Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutaminase; Glutamine; Humans; Metabolome; Neoplasms; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Ovary | 2016 |
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
Topics: Ammonia; Autophagy; Biomarkers, Tumor; Breast Neoplasms; Caveolin 1; Cell Death; Cell Hypoxia; DNA, Mitochondrial; Epithelial Cells; Glutamine; Humans; Mitochondria; Oxidative Stress; Predictive Value of Tests; Prognosis; Stromal Cells; Tumor Microenvironment | 2011 |
Treatment and care of neurotoxicity from taxane anticancer agents.
Topics: Amino Acids; Amitriptyline; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Glutamine; Growth Substances; Humans; Neurotoxicity Syndromes; Patient Care; Quality of Life; Taxoids | 2004 |
8 trial(s) available for glutamine and Breast Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
Topics: beta-Alanine; Breast Neoplasms; Female; Genome-Wide Association Study; Glutamine; Humans; Metabolome; Metabolomics; Neoplasm Proteins; Receptors, Estrogen | 2013 |
The effects of enteral glutamine on radiotherapy induced dermatitis in breast cancer.
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Female; Glutamine; Humans; Middle Aged; Radiodermatitis; Treatment Outcome; Wound Healing | 2016 |
Oxidative stress parameters in women with breast cancer undergoing neoadjuvant chemotherapy and treated with nutraceutical doses of oral glutamine.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Fluorouracil; Glutamine; Glutathione; Humans; Middle Aged; Neoadjuvant Therapy; Oxidative Stress; Prospective Studies; Statistics, Nonparametric; Thiobarbituric Acid Reactive Substances; Time Factors | 2011 |
Oral glutamine reduces radiation morbidity in breast conservation surgery.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Blood Proteins; Breast Neoplasms; Double-Blind Method; Female; Follow-Up Studies; Glutamine; Glutathione; Humans; Mastectomy, Segmental; Middle Aged; Myoglobin; Radiation Injuries; Radiotherapy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
Topics: Action Potentials; Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Electrophysiology; Glutamine; Granulocyte Colony-Stimulating Factor; Humans; Melphalan; Neural Conduction; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Stem Cell Transplantation; Thiotepa | 2005 |
Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Glutamine; Humans; Middle Aged; Models, Biological; Stomatitis; Treatment Outcome | 2007 |
Effect of glutamine on methotrexate efficacy and toxicity.
Topics: Adult; Aged; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Evaluation Studies as Topic; Female; Glutamine; Humans; Mammary Neoplasms, Experimental; Methotrexate; Middle Aged; Random Allocation; Rats; Rats, Inbred F344; Survival Analysis | 1998 |
107 other study(ies) available for glutamine and Breast Neoplasms
| Article | Year |
|---|---|
SREBP1-Induced Glutamine Synthetase Triggers a Feedforward Loop to Upregulate SREBP1 through Sp1 O-GlcNAcylation and Augments Lipid Droplet Formation in Cancer Cells.
Topics: Acetyl-CoA Carboxylase; beta-N-Acetylhexosaminidases; Breast Neoplasms; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamate-Ammonia Ligase; Glutamine; Humans; Insulin; Lipids; Liver Neoplasms; Metabolism; Promoter Regions, Genetic; Protein Biosynthesis; Signal Transduction; Sp1 Transcription Factor; Sterol Regulatory Element Binding Protein 1 | 2021 |
The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake.
Topics: Amino Acid Transport System ASC; Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diabetes Complications; Diabetes Mellitus; Female; Glutamine; Humans; Interferon-gamma; Minor Histocompatibility Antigens; Risk Factors; Signal Transduction; Sodium | 2021 |
Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Topics: Amino Acid Transport System ASC; Animals; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dipeptides; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Glutamine; Humans; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Minor Histocompatibility Antigens; Protein Binding; RNA, Circular; RNA, Messenger | 2021 |
Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Fructosephosphates; Glutamine; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycogen Synthase Kinase 3; Humans; Oxidative Stress; Transaminases | 2022 |
Metformin Treatment or PRODH/POX-Knock out Similarly Induces Apoptosis by Reprograming of Amino Acid Metabolism, TCA, Urea Cycle and Pentose Phosphate Pathway in MCF-7 Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Chromatography, Liquid; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glutamine; Glycolysis; Humans; MCF-7 Cells; Metabolomics; Metformin; Pentose Phosphate Pathway; Proline Oxidase; Tandem Mass Spectrometry; Tricarboxylic Acids; Urea | 2021 |
Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity.
Topics: Animals; Antibodies, Monoclonal; Autophagy; B7 Antigens; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Glutamine; Humans; Mice; Reactive Oxygen Species | 2022 |
Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Glucose; Glutamine; Humans; Large Neutral Amino Acid-Transporter 1; Receptor, ErbB-2; Triple Negative Breast Neoplasms | 2022 |
Breast Tissue Chemistry Measured In Vivo In Healthy Women Correlate with Breast Density and Breast Cancer Risk.
Topics: Breast Density; Breast Neoplasms; Choline; Female; Glucose; Glutamates; Glutamine; Humans; Lipids; Mammography; Phosphorylcholine; Prospective Studies; Risk Factors; Sterols; Taurine | 2022 |
Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3
Topics: Amino Acid Transport System ASC; Breast Neoplasms; Cell Line, Tumor; Female; Glutamine; Humans; Minor Histocompatibility Antigens; Nuclear Proteins; Repressor Proteins; Ubiquitin-Protein Ligases | 2022 |
Zeolitic imidazolate framework-based nanoparticles for the cascade enhancement of cancer chemodynamic therapy by targeting glutamine metabolism.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Glutamine; Humans; Nanoparticles; Reactive Oxygen Species; Zeolites | 2022 |
Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix.
Topics: Breast Neoplasms; Cancer-Associated Fibroblasts; Carcinogenesis; Collagen; delta-1-Pyrroline-5-Carboxylate Reductase; Extracellular Matrix; Female; Glutamine; Humans; Proline; Pyrroline Carboxylate Reductases | 2022 |
Extrinsic hyaluronic acid induction differentially modulates intracellular glutamine metabolism in breast cancer stem cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Glutamic Acid; Glutamine; Humans; Hyaluronic Acid; Neoplastic Stem Cells; Reactive Oxygen Species | 2022 |
Metabolic intervention liposome for targeting glutamine-addiction of breast cancer.
Topics: Adenosine Triphosphate; Breast Neoplasms; Cell Line, Tumor; Female; Glucose Oxidase; Glutamine; Humans; Liposomes; Reactive Oxygen Species | 2022 |
Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.
Topics: Breast Neoplasms; Drug Inverse Agonism; Female; Glutamine; Homeostasis; Humans; Ligands; Liver X Receptors; Orphan Nuclear Receptors; Oxidation-Reduction | 2023 |
Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer.
Topics: Breast Neoplasms; Female; Glutamine; Humans; Prognosis; RNA-Seq; Single-Cell Gene Expression Analysis; Tumor Microenvironment | 2023 |
Identification of Some Glutamic Acid Derivatives with Biological Potential by Computational Methods.
Topics: Amino Acids; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Glutamic Acid; Glutamine; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2023 |
Glutaminase (GLS1) gene expression in primary breast cancer.
Topics: Breast Neoplasms; Female; Gene Expression; Glutaminase; Glutamine; Humans; Prognosis; Triple Negative Breast Neoplasms | 2023 |
Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
Topics: Breast Neoplasms; Carcinoma; Female; Fibroblasts; Glutamine; Histones; Humans; Mechanistic Target of Rapamycin Complex 1; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factors; Tumor Microenvironment | 2023 |
Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line; Cell Line, Tumor; DNA Methylation; Female; GATA3 Transcription Factor; Genes, Tumor Suppressor; Glutaminase; Glutamine; HEK293 Cells; Humans; Liver; MCF-7 Cells; Mice; Promoter Regions, Genetic | 2019 |
UGCG influences glutamine metabolism of breast cancer cells.
Topics: Breast Neoplasms; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transport Proteins, Facilitative; Glucosyltransferases; Glutamine; Humans; MCF-7 Cells; Oxidation-Reduction; Oxidative Stress; RNA, Messenger | 2019 |
Estrogen-related receptors are targetable ROS sensors.
Topics: Animals; Antineoplastic Agents; Biosensing Techniques; Breast Neoplasms; Drug Resistance, Neoplasm; ERRalpha Estrogen-Related Receptor; Female; Gene Expression Regulation, Neoplastic; Glutamine; Glutathione; Humans; Mice; Oxidative Stress; Paclitaxel; Reactive Oxygen Species; Receptors, Estrogen; Rotenone; Signal Transduction; Tamoxifen | 2020 |
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Databases, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; MCF-7 Cells; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Models, Theoretical; Neoplasm Staging | 2020 |
Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion.
Topics: Animals; Apoptosis; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Glutamine; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells.
Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Tamoxifen; Up-Regulation | 2020 |
Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
Topics: Animals; Biosynthetic Pathways; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutamine; Glycolysis; Humans; Mice; Models, Biological; Protein Kinase C; Tumor Microenvironment | 2021 |
Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells.
Topics: Animals; Breast; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Epidermal Growth Factor; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glutamic Acid; Glutamine; Humans; Lactic Acid; Mammary Glands, Human; Proto-Oncogene Proteins p21(ras); Tumor Cells, Cultured | 2021 |
EMT-Derived Alterations in Glutamine Metabolism Sensitize Mesenchymal Breast Cells to mTOR Inhibition.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Glutamine; Glycolysis; Humans; Mesenchymal Stem Cells; Metabolome; MTOR Inhibitors; Pentose Phosphate Pathway; Tumor Cells, Cultured | 2021 |
HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways.
Topics: Adaptation, Physiological; AMP-Activated Protein Kinases; Animals; Apoptosis; Breast Neoplasms; Cell Differentiation; Cell Line; Cell Line, Tumor; Female; Glucose; Glutaminase; Glutamine; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Mice; Mice, Nude; Minor Histocompatibility Antigens; Polycomb Repressive Complex 1; Stress, Physiological; Ubiquitin-Protein Ligases | 2021 |
Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.
Topics: Adult; Arginine; Breast Neoplasms; Citrulline; Female; Genetic Predisposition to Disease; Glutamine; Humans; Mastectomy; Metabolic Clearance Rate; Middle Aged; Nitric Oxide; Postoperative Complications; Postprandial Period | 2018 |
MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.
Topics: Aldehyde Dehydrogenase; Breast Neoplasms; delta-1-Pyrroline-5-Carboxylate Reductase; Female; Gene Dosage; Gene Regulatory Networks; Genes, myc; Glutaminase; Glutamine; Humans; Proline; Proto-Oncogene Proteins c-myc; Pyrroline Carboxylate Reductases; RNA, Messenger | 2018 |
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Transport System ASC; Animals; Biomarkers, Tumor; Breast Neoplasms; Disease Models, Animal; DNA-Binding Proteins; Ephrin-A2; Female; Glutaminase; Glutamine; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Minor Histocompatibility Antigens; Muscle Proteins; Phosphoproteins; Receptor, EphA2; TEA Domain Transcription Factors; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; Tumor Cells, Cultured; YAP-Signaling Proteins | 2017 |
Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
Topics: Analysis of Variance; Animals; Breast Neoplasms; Dog Diseases; Dogs; Female; Glutamate Dehydrogenase; Glutaminase; Glutamine; Humans; Immunohistochemistry; Mammary Neoplasms, Animal; Republic of Korea | 2018 |
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells.
Topics: Amino Acid Transport System y+; Animals; Breast Neoplasms; Cell Line, Tumor; Extracellular Space; Female; Glutamic Acid; Glutamine; Homeostasis; Humans; Mammary Glands, Human; Mammary Neoplasms, Animal; Matrix Metalloproteinase 14; Mice; Neoplasm Invasiveness; rab27 GTP-Binding Proteins; Receptors, Metabotropic Glutamate; Up-Regulation | 2017 |
Small-Molecule Screen Identifies De Novo Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3.
Topics: Amino Acid Sequence; Animals; Azaserine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fibroblasts; Glutamine; Mechanistic Target of Rapamycin Complex 1; Mice, Knockout; Mice, Nude; Nucleotides; Promoter Regions, Genetic; Signal Transduction; Sirtuin 3; Small Molecule Libraries; Up-Regulation | 2018 |
Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells.
Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Aspartate Aminotransferase, Cytoplasmic; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Energy Metabolism; Female; Glutamine; Humans; Phosphoproteins; Transaminases; Transcription Factors; Tumor Cells, Cultured; YAP-Signaling Proteins | 2018 |
Asparagine and Glutamine: Co-conspirators Fueling Metastasis.
Topics: Asparagine; Biological Availability; Breast Neoplasms; Glutamine; Humans; Metabolic Networks and Pathways | 2018 |
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
Topics: Amino Acids; Benzyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Female; Glutamine; Glycolysis; Homeostasis; Humans; Leucine; Serine | 2018 |
Ligand-binding Domain-activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Movement; Cell Proliferation; Estrogen Receptor alpha; Estrogens; Female; Follow-Up Studies; Gain of Function Mutation; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; Ligands; Metabolome; Mice; Mice, Inbred BALB C; Mice, Nude; Prognosis; Protein Binding; Protein Domains; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Topics: Acylation; Animals; Biosynthetic Pathways; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; DNA Breaks, Double-Stranded; DNA Repair; Epigenesis, Genetic; Female; Genomic Instability; Glucose; Glutamine; HEK293 Cells; Hexosamines; Humans; MCF-7 Cells; Mice; Mice, Nude; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Proteomics | 2019 |
Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Glutamine; Humans; Oxidative Stress; Reactive Oxygen Species; Spectrophotometry | 2019 |
Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Topics: Animals; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Computational Biology; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression Profiling; Glutaminase; Glutamine; Humans; Immunohistochemistry; Magnetic Resonance Spectroscopy; Metabolomics; Mice; Models, Biological; Proline; Xenograft Model Antitumor Assays | 2019 |
High extracellular lactate causes reductive carboxylation in breast tissue cell lines grown under normoxic conditions.
Topics: Amino Acids; Breast Neoplasms; Carbon Isotopes; Cell Culture Techniques; Cell Line, Tumor; Citric Acid; Citric Acid Cycle; Glutamine; Glycolysis; Humans; Lactic Acid; Metabolic Flux Analysis; Oxidation-Reduction | 2019 |
Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast Cancer.
Topics: Animals; Antineoplastic Agents; Biological Transport; Breast Neoplasms; ERRalpha Estrogen-Related Receptor; Female; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Glutaminase; Glutamine; Glycolysis; Homeostasis; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; NADP; Oxidation-Reduction; Pentose Phosphate Pathway; Pyruvic Acid; Receptors, Estrogen; Tumor Cells, Cultured | 2019 |
Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.
Topics: Adult; Amino Acid Transport System ASC; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Glutamate Dehydrogenase; Glutaminase; Glutamine; Humans; Middle Aged; Minor Histocompatibility Antigens; Phenotype; Tissue Array Analysis | 2013 |
The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.
Topics: Adult; Amino Acid Transport System ASC; Breast Neoplasms; Disease-Free Survival; Female; Glutaminase; Glutamine; Humans; Kaplan-Meier Estimate; Laser Capture Microdissection; Middle Aged; Minor Histocompatibility Antigens; Neoplasm Grading; Phyllodes Tumor; Prognosis; Retrospective Studies; Sugar Alcohol Dehydrogenases; Tissue Array Analysis | 2013 |
Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study.
Topics: Aspartic Acid; Biomarkers; Brain; Breast Neoplasms; Creatine; Cross-Sectional Studies; Fatigue; Female; Glutamic Acid; Glutamine; Humans; Interleukin-6; Middle Aged; Phosphocreatine; Pilot Projects; Prognosis; Proton Magnetic Resonance Spectroscopy; Sensitivity and Specificity; Severity of Illness Index; Survivors | 2014 |
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.
Topics: Alcohol Oxidoreductases; Apoptosis; Breast Neoplasms; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Metabolome; Mitochondria; Mitochondrial Proteins; Prognosis; Proto-Oncogene Proteins c-myc; Receptors, Estrogen; RNA, Small Interfering; Survival Analysis; Transcriptome; Wnt Signaling Pathway | 2014 |
Transient state microscopy probes patterns of altered oxygen consumption in cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Eosine Yellowish-(YS); Female; Fluorescent Dyes; Glucose; Glutamine; Glycolysis; Humans; MCF-7 Cells; Metabolic Networks and Pathways; Microscopy, Fluorescence; Neoplasms; Oxidative Phosphorylation; Oxygen Consumption | 2014 |
Plasma amino acid profiles of breast cancer patients early in the trajectory of the disease differ from healthy comparison groups.
Topics: Adolescent; Adult; Amino Acids; Body Composition; Breast Neoplasms; Case-Control Studies; Energy Intake; Female; Glutamic Acid; Glutamine; Histidine; Humans; Leucine; Middle Aged; Threonine | 2014 |
Glutamate enrichment as new diagnostic opportunity in breast cancer.
Topics: Biomarkers; Breast Neoplasms; Case-Control Studies; Cluster Analysis; Female; Gene Expression Profiling; Glutamic Acid; Glutamine; Humans; Lymphatic Metastasis; Metabolomics; Neoplasm Grading; Neoplasm Staging; Peroxisome Proliferator-Activated Receptors; Prognosis; Receptors, Estrogen; Signal Transduction | 2015 |
Energy metabolism during anchorage-independence. Induction by osteopontin-c.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Breast; Breast Neoplasms; Energy Metabolism; Female; Gene Expression Regulation, Neoplastic; Glutamine; Glycerol; Glycolysis; Humans; MCF-7 Cells; Molecular Sequence Data; Mutation; Neoplasm Invasiveness; Osteopontin; Oxidation-Reduction; Oxidoreductases; Peroxides; Protein Isoforms; Signal Transduction | 2014 |
MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Topics: Animals; Apoptosis; Autophagy; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Glutamine; Humans; Proto-Oncogene Proteins c-myc; Rats, Sprague-Dawley; Signal Transduction; Unfolded Protein Response; Up-Regulation | 2014 |
Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Paclitaxel; RNA Interference; RNA, Small Interfering; Up-Regulation | 2015 |
Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Glutamine; Humans; MCF-7 Cells; Molecular Targeted Therapy; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2 | 2015 |
IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glucose; Glucose Transporter Type 1; Glutamine; Humans; Interleukin-4; Mammary Neoplasms, Animal; Membrane Transport Proteins; Mice; Receptors, Interleukin-4 | 2015 |
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.
Topics: Aminooxyacetic Acid; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Enzyme Inhibitors; Female; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Xenograft Model Antitumor Assays | 2015 |
Nutrient depletion and metabolic profiles in breast carcinoma cell lines measured with a label-free platform.
Topics: Actins; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Survival; Cytochalasin B; Glucose; Glucose Transporter Type 1; Glutamine; Humans; Hydrogen-Ion Concentration; Lactic Acid; MCF-7 Cells; Metabolome; Oxazines; Oxygen; RNA, Messenger; Xanthenes | 2015 |
The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.
Topics: 14-3-3 Proteins; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease-Free Survival; Energy Metabolism; Exoribonucleases; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glutamine; Glycolysis; HCT116 Cells; Humans; Middle Aged; Organelle Biogenesis; Prognosis; Proteolysis; Proto-Oncogene Proteins c-myc; Ubiquitination; Young Adult | 2015 |
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
Topics: Animals; Breast Neoplasms; Carbon Isotopes; Cell Hypoxia; Cell Line, Tumor; Female; Gas Chromatography-Mass Spectrometry; Glutamine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Metabolic Engineering; Metabolome; Mice; Mice, Inbred BALB C; Oxidative Phosphorylation; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA Interference; RNA, Small Interfering | 2015 |
The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Ephrin-A1; Female; Glutamine; Humans; Mice; Receptor, EphA2; Signal Transduction | 2016 |
AKT-p53 axis protect cancer cells from autophagic cell death during nutrition deprivation.
Topics: Autophagy; Breast Neoplasms; Cell Line, Tumor; Female; Glucose; Glutamine; Humans; MCF-7 Cells; Protein Stability; Proto-Oncogene Proteins c-akt; Tumor Suppressor Protein p53 | 2016 |
[Association of the Arg399Gln polymorphisms of the XRCC1 gene with breast cancer risk in Kyrgiz women].
Topics: Adult; Aged; Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; DNA, Neoplasm; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Humans; Kyrgyzstan; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Assessment; Risk Factors; X-ray Repair Cross Complementing Protein 1 | 2015 |
ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Respiration; Cytoprotection; Disease Models, Animal; Drug Resistance, Neoplasm; ERRalpha Estrogen-Related Receptor; Female; Glucose; Glutamine; Humans; Imidazoles; Lactates; Mice, Inbred NOD; Mice, SCID; Mitochondria; Models, Biological; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinolines; Reactive Oxygen Species; Receptors, Estrogen; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2016 |
Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cations; Cell Membrane; Cell Survival; Cell-Penetrating Peptides; Drug Delivery Systems; Female; Glutamine; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Lysine; Methotrexate; Mutation; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies.
Topics: Algorithms; Breast Neoplasms; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Genes, Mitochondrial; Genome, Mitochondrial; Glutamine; Humans; Reproducibility of Results; Stromal Cells; Up-Regulation | 2017 |
Collagen Matrix Density Drives the Metabolic Shift in Breast Cancer Cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Citric Acid Cycle; Collagen; Energy Metabolism; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; Mitochondria; Models, Biological; Oxygen; Reactive Oxygen Species; Tumor Microenvironment | 2016 |
Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glutamine; HeLa Cells; Humans; STAT3 Transcription Factor | 2017 |
Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Female; Glutamine; Humans; Poly (ADP-Ribose) Polymerase-1; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA Interference; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP | 2017 |
Acivicin with glutaminase regulates proliferation and invasion of human MCF-7 and OAW-42 cells--an in vitro study.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Female; Glutaminase; Glutamine; Humans; In Vitro Techniques; Isoxazoles; Laminin; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Ovarian Neoplasms; Proteoglycans; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2008 |
L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Female; Glutamine; Humans; I-kappa B Proteins; Jurkat Cells; Kinetics; Leukemia, T-Cell; NF-KappaB Inhibitor alpha; Organometallic Compounds; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Ubiquitin | 2008 |
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.
Topics: Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamine; Humans; Nigeria; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Premenopause; Receptors, Leptin; Risk Factors; Signal Transduction | 2008 |
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Topics: Acetylcysteine; Amino Acid Transport System ASC; Antioxidants; Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression; Glutamine; Glutathione; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen | 2011 |
Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potential.
Topics: Breast Neoplasms; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chromans; Citric Acid Cycle; Female; Glucose; Glutamine; Glycolysis; Humans; Hypoglycemic Agents; Membrane Potential, Mitochondrial; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured | 2011 |
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.
Topics: Breast; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Coculture Techniques; Culture Media; Epithelium; Female; GATA3 Transcription Factor; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamate-Ammonia Ligase; Glutaminase; Glutamine; Humans; Molecular Targeted Therapy; Nutritional Physiological Phenomena; Phenotype; Promoter Regions, Genetic | 2011 |
PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Glioblastoma; Glutamine; Humans; Male; Mice; Mice, Transgenic; Positron-Emission Tomography; Rats | 2011 |
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Topics: Acetylation; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glutamine; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Repressor Proteins | 2012 |
Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay.
Topics: Algorithms; Amino Acid Sequence; Breast Neoplasms; Cell Hypoxia; Cell Line; Cell Proliferation; Chromatography, Liquid; Citric Acid Cycle; Energy Metabolism; Estradiol; Galactose; Glucose; Glutamine; Glycolysis; Humans; Linear Models; Mass Spectrometry; MCF-7 Cells; Metabolic Networks and Pathways; Molecular Sequence Data; Pentose Phosphate Pathway; Peptides; Proteome; Proteomics | 2012 |
Selection of metastatic breast cancer cells based on adaptability of their metabolic state.
Topics: Adaptation, Biological; Animals; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression; Glutamine; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Proto-Oncogene Proteins c-myc; Vimentin | 2012 |
Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype.
Topics: Apoptosis; Benzophenanthridines; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3B; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Histone-Lysine N-Methyltransferase; Histones; Humans; Nuclear Proteins; Promoter Regions, Genetic; Sirtuin 1; Transcription Factors | 2012 |
Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex.
Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; ATPases Associated with Diverse Cellular Activities; Breast Neoplasms; Carcinoma; Carrier Proteins; Cells, Cultured; Citric Acid Cycle; DNA Helicases; Energy Metabolism; Female; Glucose; Glutamine; Humans; Intracellular Signaling Peptides and Proteins; Lysosomes; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Protein Binding; Protein Multimerization; Protein Transport; Proteins; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Statistics, Nonparametric; Stress, Physiological; Telomere-Binding Proteins; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2013 |
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Glutamine; Glycine; Humans; Isoleucine; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Proline; Research; Serine; Threonine; Tyrosine | 1964 |
Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress.
Topics: Adenocarcinoma; Amino Acids; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Hypoxia; Cobalt; DNA Damage; DNA, Neoplasm; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Humans; Interleukin-8; Neovascularization, Pathologic; RNA, Messenger; RNA, Neoplasm; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured; Tunicamycin; Up-Regulation; Vascular Endothelial Growth Factors | 2004 |
Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1.
Topics: Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL1; Chemokines, CXC; Curcumin; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-8; NF-kappa B; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Transcription Factor AP-1; Transcription, Genetic; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice.
Topics: Amino Acid Substitution; Animals; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Collagen; Enzyme Activation; Extracellular Matrix; Female; Genetic Therapy; Genetic Vectors; Glutamine; Hepatocyte Growth Factor; Humans; Lentivirus; Methionine; Mice; Mice, Nude; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Protein Engineering; Protein-Tyrosine Kinases; Recombinant Proteins; Transduction, Genetic; Transplantation, Heterologous; Tumor Burden | 2004 |
Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Breast Neoplasms; Calorimetry; Cell Cycle Proteins; Crystallography, X-Ray; DNA Damage; DNA-Binding Proteins; Escherichia coli; Glutamic Acid; Glutamine; Glutathione Transferase; Histones; Humans; Models, Molecular; Models, Statistical; Molecular Sequence Data; Nuclear Proteins; Peptides; Phosphates; Phosphopeptides; Phosphorylation; Protein Conformation; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Serine; Trans-Activators; Tyrosine | 2005 |
Loss of RAB25 expression in breast cancer.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 3; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Glutamine; Humans; In Situ Hybridization, Fluorescence; Leucine; Mice; Mice, Nude; Mutation; Plasmids; rab GTP-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Transduction, Genetic | 2006 |
Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis.
Topics: Algorithms; Amino Acids; Biosynthetic Pathways; Breast Neoplasms; Carbon Isotopes; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Estradiol; Female; Glucose; Glutamic Acid; Glutamine; Humans; Lactic Acid; Mitochondria; Models, Biological; Nuclear Magnetic Resonance, Biomolecular | 2006 |
Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells.
Topics: Animals; Breast Neoplasms; Gene Expression; Glutaminase; Glutamine; Hexosamines; Humans; Mice; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Proteomics; RNA Interference; Sp1 Transcription Factor; Tumor Cells, Cultured; Uridine Diphosphate N-Acetylglucosamine | 2008 |
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Topics: Alanine; Arginine; Biomarkers, Tumor; Breast Neoplasms; Centrosome; DNA, Complementary; Factor Analysis, Statistical; Female; Genes, BRCA1; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Glycine; Humans; Immunohistochemistry; Keratins; Mutation, Missense; Nucleic Acid Amplification Techniques; Plasmids; Polymorphism, Single Nucleotide; Predictive Value of Tests; Receptors, Estrogen; Risk Assessment; Risk Factors; Sequence Analysis, DNA; Valine | 2007 |
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
Topics: Adult; Age of Onset; Breast Neoplasms; Fanconi Anemia Complementation Group N Protein; Female; Founder Effect; France; Genetic Predisposition to Disease; Glutamine; Humans; Infant, Newborn; Middle Aged; Mutation; Nuclear Proteins; Quebec; Tumor Suppressor Proteins | 2007 |
Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
Topics: Adenocarcinoma; Blood; Breast Neoplasms; Cell Cycle; Cell Line; Culture Media; Estradiol; Estrogens; Female; Glutamine; Humans; Hydrocortisone; Insulin; Kinetics; Prolactin; Receptors, Estrogen; Tamoxifen | 1984 |
Effect of treatment with glutaurine on human antibody-dependent cell-mediated cytotoxicity (ADCC).
Topics: Adult; Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Colonic Neoplasms; Female; Glutamine; Hodgkin Disease; Humans; Immunoglobulin Fc Fragments; Liver Neoplasms; Lymphocytes; Lymphoma; Male; Middle Aged; Multiple Myeloma; Parathyroid Hormone; Taurine; Urinary Bladder Neoplasms | 1981 |
Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.
Topics: Adenosine Monophosphate; Angiotensin-Converting Enzyme Inhibitors; Annexin A2; Breast Neoplasms; Endonucleases; Female; Glutamine; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycogen; Glycolysis; Humans; Isoelectric Focusing; Isoenzymes; Kinetics; Malate Dehydrogenase; Molecular Weight; Peptide Fragments; RNA; Tumor Cells, Cultured | 1996 |
Differential effect of glucose deprivation on MAPK activation in drug sensitive human breast carcinoma MCF-7 and multidrug resistant MCF-7/ADR cells.
Topics: Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Doxorubicin; Drug Resistance, Multiple; Enzyme Activation; Female; Glucose; Glutamic Acid; Glutamine; Humans; Kinetics; MAP Kinase Kinase Kinase 1; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; ras Proteins; Signal Transduction; Tumor Cells, Cultured | 1997 |
Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors.
Topics: Animals; Breast Neoplasms; Cell Division; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Humans; Mice; Mice, Nude; Protein Biosynthesis; RNA, Messenger; Transcription, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells.
Topics: Acetylcysteine; Breast Neoplasms; Carcinoma; Cell Death; Drug Resistance, Multiple; Enzyme Activation; Female; Glucose; Glutamic Acid; Glutamine; Glutathione; Glutathione Disulfide; Humans; Mitogen-Activated Protein Kinase 1; Oxidative Stress; Signal Transduction; Tumor Cells, Cultured | 1998 |
Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines.
Topics: Biological Transport; Breast Neoplasms; Carbon Dioxide; Cell Division; Culture Media; Cystine; Glutamic Acid; Glutamine; Glutathione; Humans; Kinetics; Sodium; Tumor Cells, Cultured | 1998 |
Glutamine deprivation induces the expression of GADD45 and GADD153 primarily by mRNA stabilization.
Topics: Breast Neoplasms; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Cell Division; Cell Line; DNA-Binding Proteins; Endoplasmic Reticulum Chaperone BiP; GADD45 Proteins; Glutamine; Heat-Shock Proteins; Humans; Hydrolysis; Intracellular Signaling Peptides and Proteins; Molecular Chaperones; Proteins; RNA, Messenger; Transcription Factor CHOP; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Aminopeptidase activities in breast cancer tissue.
Topics: Aminopeptidases; Aspartic Acid; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Membrane; Female; Fluorometry; Glutamine; Glutamyl Aminopeptidase; Humans; Middle Aged; Solubility | 1999 |
Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase.
Topics: Amino Acid Sequence; Base Sequence; Breast Neoplasms; Cloning, Molecular; Escherichia coli; Female; Gene Expression; Gene Library; Glutaminase; Glutamine; Humans; Molecular Sequence Data; Neoplasm Proteins; Recombinant Proteins; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Tissue Distribution | 2000 |
Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Breast Neoplasms; Gastrointestinal Diseases; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Middle Aged; Paclitaxel; Retrospective Studies; Suspensions; Transplantation, Autologous | 2000 |
Polymorphic repeat in AIB1 does not alter breast cancer risk.
Topics: Adult; Breast Neoplasms; Case-Control Studies; DNA Primers; DNA, Neoplasm; Female; Genotype; Glutamine; Humans; Linkage Disequilibrium; Microsatellite Repeats; Middle Aged; Nuclear Receptor Coactivator 3; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Sequence Analysis, DNA; Transcription Factors | 2000 |
Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast car
Topics: Breast Neoplasms; Cysteine; Dimerization; Dipeptides; DNA Mutational Analysis; Enzyme Activation; Female; Fibrosarcoma; Glutamine; Humans; Hydroxamic Acids; Indoles; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mutagenesis, Site-Directed; Protease Inhibitors; Protein Processing, Post-Translational | 2001 |
Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase.
Topics: Amino Acids; Asparaginase; Asparagine; Breast Neoplasms; Cell Line; Cell Survival; Cells, Cultured; DNA, Neoplasm; Escherichia coli; Female; Glutamine; Glycoproteins; Humans; Melanoma; Neoplasm Proteins; Pancreatic Neoplasms; RNA, Neoplasm; Vibrio | 1978 |
In vitro effect of extracellular AMP on MCF-7 breast cancer cells: inhibition of glycolysis and cell proliferation.
Topics: Adenosine Monophosphate; Breast Neoplasms; Cell Division; Extracellular Space; Glutamine; Glycolysis; Humans; Tumor Cells, Cultured | 1992 |
Availability of glutamine from peptides and acetylglutamine for human tumor-cell cultures.
Topics: Breast Neoplasms; Cell Division; Dipeptides; DNA; Glutamine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured | 1989 |
L-glutamine: a major substrate for tumor cells in vivo?
Topics: Animals; Breast Neoplasms; Carcinosarcoma; Energy Metabolism; Female; Glutamine; Humans; Hydrogen-Ion Concentration; Male; Mathematics; Models, Biological; Neoplasm Transplantation; Oxygen Consumption; Rats; Rats, Inbred Strains; Transplantation, Heterologous | 1987 |